InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Blaug Suzanne, 董事. Insider active across 1 company, notably FIBROGEN INC. In total, 3 reports have been published. History available since 26 May 2021. The latest transaction was filed on 7 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Blaug Suzanne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报3 总计
8,289 股0Common StockSEC:0001209191-23-036079:0
15,777 股0Common StockSEC:0001209191-22-038601:0
4,700 股0Common StockSEC:0001209191-21-036666:0
3 条申报中的 3 条
About Blaug Suzanne
Suzanne Blaug serves as a Director at FibroGen Inc. As a board member, she contributes to overseeing the company's operations and shaping its strategy. Suzanne brings valuable expertise in the biopharmaceutical sector, helping FibroGen innovate and grow. Her commitment to corporate governance is essential for ensuring transparency and accountability.
